Russia begins human trials for a personalized mRNA cancer vaccine developed by the Gamaleya Center, aiming to transform cancer treatment through patient-specific immunotherapy.
Russia begins human trials for a personalized mRNA cancer vaccine developed by the Gamaleya Center, aiming to transform cancer treatment through patient-specific immunotherapy.